Lionel Apetoh
Apetoh, Lionel
VIAF ID: 188652572 (Personal)
Permalink: http://viaf.org/viaf/188652572
Preferred Forms
- 100 1 _ ‡a Apetoh, Lionel
- 100 1 _ ‡a Apetoh, Lionel
- 100 0 _ ‡a Lionel Apetoh
4xx's: Alternate Name Forms (3)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Analyse des mécanismes moléculaires et cellulaires conduisant à une inflammation dans l'intestin et une progression tumorale induits par la perte de la sous-unité d'intégrine Alpha6 chez la souris | |
Analysis of the molecular signaling in a tumor progression model associated with inflammation in the intestine. | |
The anticancer immune response: indispensable for therapeutic success? | |
The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. | |
Asthme allergique induit par un allergène d'acarien, House Dust Mite (HDM) : rôles de la caspase-1 et de la protéine kinase C thêta (PKC-θ) | |
L’autophagie : Un nouveau modulateur de la mort cellulaire immunogène dans le traitement des cancers. | |
Biology of CD73+CD4+ T lymphocytes and sensitivity to Treg-mediated immunosuppression. | |
La calréticuline détermine l’immunogénicité de la chimiothérapie et de la radiothérapie antitumorales | |
Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity | |
Cancer is not just a disease of a tissue: It is a host disease | |
Caspase-1 activation by NLRP3 inflammasome dampens IL-33-dependent house dust mite-induced allergic lung inflammation | |
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1. | |
Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy | |
Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity? | |
The critical role of IL-15 in the antitumor effects mediated by the combination therapy imatinib and IL-2. | |
Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth | |
Danger signals: Chemotherapy enhancers? | |
Étude de la régulation transcriptionnelle des lymphocytes Th9 | |
Etude du role de l'IL-21 dans l'interaction entre les cellules à cytotoxicité naturelle et les lymphocytes T CD4 chez l'homme | |
Etude du rôle de STING dans la biologie des lymphocytes T CD4 : application en immunothérapie anticancéreuse | |
Fas signaling-mediated TH9 cell differentiation favors bowel inflammation and antitumor functions | |
How do alarmins affect Th9 cell differentiation?. | |
HSP70 is a negative regulator of NLRP3 inflammasome activation | |
Human TH17 and regulatory T cells : shared developmental mechanisms and relationship with the intestinal microbiota. | |
Immune effects of 5-fluorouracil: Ambivalence matters | |
Immunogenic death of colon cancer cells treated with oxaliplatin | |
Immunogénicité de la mort cellulaire tumorale provoquée par les thérapies anticancéreuses | |
Immunogenicity of anthracyclines: moving towards more personalized medicine | |
The immunosuppressive enzyme IL4I1 promotes FoxP3(+) regulatory T lymphocyte differentiation. | |
Immunotherapeutic properties of chemotherapy | |
Inhibition of colon cancer growth by docosahexaenoic acid involves autocrine production of TNFα. | |
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy | |
The interplay between the immune system and chemotherapy: emerging methods for optimizing therapy | |
The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide | |
IRF8-dependent molecular complexes control the Th9 transcriptional program. | |
Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells | |
Lymphocytes T régulateurs induits par Faecalibacterium prausnitzii : modalités de leur induction et signification fonctionnelle | |
Les lymphocytes Th17 et T régulateurs : mécanismes de développement partagés et relation avec le microbiote intestinal | |
Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint Inhibitors | |
Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference | |
Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies | |
Molecular pathways in the induction of interleukin-27-driven regulatory type 1 cells. | |
A novel dendritic cell subset involved in tumor immunosurveillance | |
Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells | |
Phenolic extract from oleaster (Olea europaea var. Sylvestris) leaves reduces colon cancer growth and induces caspase-dependent apoptosis in colon cancer cells via the mitochondrial apoptotic pathway | |
Prospective study of the evolution of blood lymphoid immune parameters during dacarbazine chemotherapy in metastatic and locally advanced melanoma patients | |
Protection against malaria in mice is induced by blood stage-arresting histamine-releasing factor (HRF)-deficient parasites | |
Protein kinase Cθ controls type 2 innate lymphoid cell and TH2 responses to house dust mite allergen | |
Radiotherapy and immunogenic cell death | |
Rationale for stimulator of interferon genes-targeted cancer immunotherapy | |
The receptor NLRP3 is a transcriptional regulator of TH2 differentiation | |
Relation between bevacizumab dose intensity and high-grade glioma survival: a retrospective study in two large cohorts. | |
Rôle de l'enzyme IL4-induced gene 1 (IL4l1) en contexte tumoral et sur la physiologie des lymphocytes B | |
Role of IL-21 in the interaction between NK cells and CD4 T cells in humans. | |
Role of myeloid-derived suppressor cells in tumor immunotherapy | |
Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells | |
Signalling strength determines proapoptotic functions of STING. | |
Sirtuin-1 Activation Controls Tumor Growth by Impeding Th17 Differentiation via STAT3 Deacetylation | |
Socs3 induction by PPARγ restrains cancer-promoting inflammation. | |
SOCS3 transactivation by PPARγ prevents IL-17-driven cancer growth | |
Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression | |
STING-dependent sensing of self-DNA drives silica-induced lung inflammation | |
Stress-Induced Depressive Behaviors Require a Functional NLRP3 Inflammasome. | |
Study of the transcriptional regulation of CD4 T cells in cancer : potential application in antitumor immunotherapy. | |
T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival | |
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity | |
Th9 cells: a new population of helper T cells | |
Th9 cells: a novel CD4 T-cell subset in the immune war against cancer. | |
Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells. | |
The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells | |
Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity | |
Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients | |
The tumor microenvironment impairs Th1 IFNγ secretion through alternative splicing modifications of Irf1 pre-mRNA | |
Type 1 regulatory T cells (Tr1) in autoimmunity | |
Witch hunt against tumor cells enhanced by dendritic cells |